Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 26, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2,094	997	637	551	539	430
Market Cap Growth	147.82%	56.67%	15.47%	2.38%	25.17%	-7.67%
Enterprise Value	2,202	1,128	710	475	432	381
Last Close Price	140.21	59.41	35.12	26.80	23.62	17.28
PE Ratio	5.64	4.05	6.56	3.33	4.33	3.94
Forward PE	-	6.22	6.22	6.22	6.22	6.22
PS Ratio	1.23	0.73	0.63	0.50	0.51	0.43
PB Ratio	2.46	1.20	0.94	0.69	0.77	0.66
P/TBV Ratio	1.71	1.20	0.94	0.70	0.77	0.66
P/FCF Ratio	13.99	51.55	67.35	15.98	3.89	-
P/OCF Ratio	4.07	3.79	7.19	10.64	3.32	-
EV/Sales Ratio	1.29	0.83	0.71	0.43	0.41	0.38
EV/EBITDA Ratio	4.69	3.75	8.04	2.29	2.76	2.74
EV/EBIT Ratio	4.90	3.95	9.26	2.47	2.76	2.75
EV/FCF Ratio	14.71	58.32	75.14	13.76	3.12	-
Debt / Equity Ratio	0.26	0.28	0.24	0.07	-	0.00
Debt / EBITDA Ratio	0.48	0.78	1.77	0.28	-	0.00
Debt / FCF Ratio	1.49	12.28	17.38	1.69	-	-
Asset Turnover	-	0.99	0.84	0.99	1.03	0.99
Inventory Turnover	-	1.94	2.09	2.56	2.59	2.49
Quick Ratio	0.97	1.04	1.05	1.90	1.77	1.42
Current Ratio	1.77	2.25	2.21	3.08	2.56	2.57
Return on Equity (ROE)	-	32.54%	13.17%	22.13%	18.31%	17.36%
Return on Assets (ROA)	-	12.96%	3.98%	10.73%	9.50%	8.49%
Return on Capital (ROIC)	-	18.65%	5.65%	15.43%	14.39%	13.79%
Return on Capital Employed (ROCE)	42.80%	27.30%	9.70%	22.40%	22.00%	21.00%
Earnings Yield	17.74%	24.67%	15.25%	30.06%	23.08%	25.37%
FCF Yield	7.15%	1.94%	1.49%	6.26%	25.73%	-7.04%
Dividend Yield	9.44%	21.59%	14.24%	18.65%	16.94%	15.50%
Payout Ratio	37.20%	34.75%	103.84%	45.37%	62.53%	50.35%
Total Shareholder Return	9.44%	21.59%	14.24%	18.65%	16.94%	15.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.